Drug recall · May 23, 2018
Amlodipine and Benazapril HCL Capsules recall
Why: cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedure
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amlodipine and Benazapril HCL Capsules, USP, 5 mg/40 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-6899-01
- Lots / codes
Lot Numbers# 3083008 and 3086124, exp Jan 2019
- Quantity
- 12,924 bottles
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Product was distributed throughout United States
- Initiated
- April 24, 2018 · Voluntary: Firm initiated
- Classified
- May 17, 2018
- Reported
- May 23, 2018
- Ended
- June 20, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amlodipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.